Loading...

PerCP anti-mouse CD4 Antibody

Pricing & Availability
Clone
RM4-5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RM4-5_PerCP_011508
C57BL/6 mouse splenocytes stained with CD4 (clone RM4-5) PerCP (filled histogram) or rat IgG2a, κ PerCP isotype control (open histogram).
  • RM4-5_PerCP_011508
    C57BL/6 mouse splenocytes stained with CD4 (clone RM4-5) PerCP (filled histogram) or rat IgG2a, κ PerCP isotype control (open histogram).
Compare all formats See PerCP spectral data
Cat # Size Price Quantity Check Availability Save
100537 25 µg 80€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100538 100 µg 190€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes and a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a co-receptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosine kinase lck.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
BALB/c mouse thymocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP has a maximum absorption of 482 nm and a maximum emission of 675 nm.

Excitation Laser
Blue Laser (488 nm)
Application Notes

The RM4-5 antibody blocks the binding of GK1.5 antibody and H129.19 antibody to CD4+ T cells, but not RM4-4 antibody. Additional reported applications (for the relevant formats) include: blocking of ligand binding, in vivo depletion of CD4+ cells1, and immunohistochemistry of acetone-fixed frozen tissue sections2,3,11 and paraffin-embedded sections11. Clone RM4-5 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. Instead, acetone frozen or zinc-fixed paraffin sections are recommended. The Ultra-LEAF™ Purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100575 and 100576).

Application References

(PubMed link indicates BioLegend citation)
  1. Kruisbeek AM. 1991. In Curr. Protocols Immunol. pp. 4.1.1-4.1.5. (Block, Deplete)
  2. Nitta H, et al. 1997. Cell Vision 4:73. (IHC)
  3. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045.
  4. Muraille E, et al. 2003. Infect. Immun. 71:2704. (IHC)
  5. León-Ponte M, et al. 2007. Blood 109:3139. (FC)
  6. Bourdeau A, et al. 2007. Blood doi:10.1182/blood-2006-08-044370. (FC)
  7. Matsumoto M, et al. 2007.J. Immunol.178:2499. PubMed
  8. Shigeta A, et al. 2008. Blood 112:4915. PubMed
  9. Zaborsky N, et al. 2010. J. Immunol. 184:725. PubMed
  10. Rodrigues-Manzanet R, et al. 2010. P. Natl Acad Sci USA 107:8706. PubMed
  11. Whiteland JL, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
Product Citations
  1. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  2. Yang R, et al. 2020. Cell Death Dis. 0.877083333. PubMed
  3. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  4. Martens R, et al. 2020. Nat Commun. 11:1114. PubMed
  5. Fitzgerald B, et al. 2021. Cell Rep Methods. 1:. PubMed
  6. Swadling L, et al. 2020. Cell Rep. 30:687. PubMed
  7. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  8. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  9. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  10. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  11. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  12. Roy S, et al. 2020. Sci Rep. 10:10992. PubMed
  13. Shrivastava T, et al. 2021. Front Immunol. 12:641447. PubMed
  14. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  15. Thauland T, et al. 2014. J Immunol. 193:5894. PubMed
  16. Köchl R, et al. 2020. Elife. 9:00. PubMed
  17. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  18. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  19. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
  20. Jacque E, et al. 2015. J Exp Med. 212:883. PubMed
  21. Schuldt N, et al. 2015. PLoS One. 10: 0145762. PubMed
  22. Sood S, et al. 2016. J Immunol. 197: 429 - 440. PubMed
  23. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  24. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  25. Robles-Oteiza C, et al. 2021. Dis Model Mech. 14:. PubMed
  26. Derada Troletti C, et al. 2021. Cell Reports. 35(9):109201. PubMed
  27. Riva A, et al. 2017. PLoS One.. 10.1371/journal.pone.0181964. PubMed
  28. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  29. Roy S, et al. 2021. Nat Commun. 12:3182. PubMed
  30. Hartwig S, et al. 2014. PLoS One. 9:90720. PubMed
  31. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  32. Menon M, et al. 2014. PLoS Genet. 10:1004558. PubMed
  33. Schaftenaar FH, et al. 2019. Sci Rep. 9:17391. PubMed
  34. Tao Z, et al. 2022. Cells. 11:. PubMed
  35. Jacque E, et al. 2014. J Exp Med. 211:2085. PubMed
  36. Tang L, et al. 2022. Front Immunol. 12:770402. PubMed
  37. Sturmlechner I, et al. 2021. Science. 374:eabb3420. PubMed
  38. Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed
  39. Ito Y, et al. 2021. Cell Reports. 35(4):109052. PubMed
  40. Yuan M, et al. 2017. Hum Reprod. 32:94. PubMed
  41. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
RRID
AB_893331 (BioLegend Cat. No. 100537)
AB_893325 (BioLegend Cat. No. 100538)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

How stable is PerCP/Cy5.5 tandem as compared to PerCP alone?

PerCP/Cy5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.
Go To Top Version: 3    Revision Date: 01.29.2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD4

  • Biotin anti-mouse CD4

  • FITC anti-mouse CD4

  • PE anti-mouse CD4

  • PE/Cyanine5 anti-mouse CD4

  • Purified anti-mouse CD4

  • PE/Cyanine7 anti-mouse CD4

  • APC/Cyanine7 anti-mouse CD4

  • Alexa Fluor® 647 anti-mouse CD4

  • Alexa Fluor® 488 anti-mouse CD4

  • Pacific Blue™ anti-mouse CD4

  • Alexa Fluor® 700 anti-mouse CD4

  • PerCP anti-mouse CD4

  • PerCP/Cyanine5.5 anti-mouse CD4

  • Brilliant Violet 421™ anti-mouse CD4

  • APC/Fire™ 750 anti-mouse CD4

  • Brilliant Violet 570™ anti-mouse CD4

  • Brilliant Violet 605™ anti-mouse CD4

  • Brilliant Violet 650™ anti-mouse CD4

  • Brilliant Violet 711™ anti-mouse CD4

  • Brilliant Violet 785™ anti-mouse CD4

  • Brilliant Violet 510™ anti-mouse CD4

  • Purified anti-mouse CD4 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse CD4

  • TotalSeq™-A0001 anti-mouse CD4

  • TotalSeq™-B0001 anti-mouse CD4

  • TotalSeq™-C0001 anti-mouse CD4

  • Ultra-LEAF™ Purified anti-mouse CD4

  • Spark Violet™ 423 anti-mouse CD4 (L3T4) Antibody
ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account